Device
Erchonia MLS
Erchonia MLS is a medical device with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Completed1
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
terminated133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Study of Low Level Laser Therapy to Treat Low Back Pain
NCT01835756
terminatednot_applicable
Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp
NCT01292746
withdrawnnot_applicable
Study to See How Low Level Laser Light Affects Subcutaneous Fat Around the Hips and Waist
NCT01292564
Clinical Trials (3)
Showing 3 of 3 trials
NCT01835756Not Applicable
Study of Low Level Laser Therapy to Treat Low Back Pain
NCT01292746Not Applicable
Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp
NCT01292564Not Applicable
Study to See How Low Level Laser Light Affects Subcutaneous Fat Around the Hips and Waist
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3